191 related articles for article (PubMed ID: 28993875)
1. Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis.
Zhang L; Sander JW; Zhang L; Jiang XY; Wang W; Shuang K; Abdulaziz ATA; Wu MQ; Chi XS; Li JM; Zhou D
J Neurol; 2017 Dec; 264(12):2378-2386. PubMed ID: 28993875
[TBL] [Abstract][Full Text] [Related]
2. Late-onset anti-N-methyl-d-aspartate receptor encephalitis in China.
Zhang L; Liu X; Jiang XY; Wang YH; Li JM; Zhou D
Epilepsy Behav; 2018 Jul; 84():22-28. PubMed ID: 29734104
[TBL] [Abstract][Full Text] [Related]
3. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China.
Wang W; Li JM; Hu FY; Wang R; Hong Z; He L; Zhou D
Eur J Neurol; 2016 Mar; 23(3):621-9. PubMed ID: 26563553
[TBL] [Abstract][Full Text] [Related]
4. Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.
Ho AC; Chan SH; Chan E; Wong SS; Fung ST; Cherk SW; Fung EL; Ma KH; Tsui KW; Yau EK; Wong VC
Brain Dev; 2018 Jun; 40(6):473-479. PubMed ID: 29599011
[TBL] [Abstract][Full Text] [Related]
5. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit.
Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X
Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725
[TBL] [Abstract][Full Text] [Related]
6. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions.
Kuppuswamy PS; Takala CR; Sola CL
Gen Hosp Psychiatry; 2014; 36(4):388-91. PubMed ID: 24731834
[TBL] [Abstract][Full Text] [Related]
7. Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients.
Wang J; Zhang B; Zhang M; Chen J; Deng H; Wang Q; Sun X
Neuropsychobiology; 2017; 75(2):72-80. PubMed ID: 29065417
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.
Huang Q; Wu Y; Qin R; Wei X; Ma M
J Neurol; 2016 Dec; 263(12):2446-2455. PubMed ID: 27632180
[TBL] [Abstract][Full Text] [Related]
9. Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry.
Sakamoto S; Kawai H; Okahisa Y; Tsutsui K; Kanbayashi T; Tanaka K; Mizuki Y; Takaki M; Yamada N
Acta Med Okayama; 2019 Jun; 73(3):189-195. PubMed ID: 31235965
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Function and Autoimmune Indications in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Ma X; Yin Q; Zeng Z; Wang C; Yang Y; Guo S
Neuroimmunomodulation; 2018; 25(2):110-117. PubMed ID: 30157483
[TBL] [Abstract][Full Text] [Related]
11. Long-term cognitive and neuropsychiatric outcomes in patients with anti-NMDAR encephalitis.
Liu X; Zhang L; Chen C; Gong X; Lin J; An D; Zhou D; Hong Z
Acta Neurol Scand; 2019 Dec; 140(6):414-421. PubMed ID: 31483852
[TBL] [Abstract][Full Text] [Related]
12. Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: A case series.
Lagarde S; Lepine A; Caietta E; Pelletier F; Boucraut J; Chabrol B; Milh M; Guedj E
Brain Dev; 2016 May; 38(5):461-70. PubMed ID: 26542469
[TBL] [Abstract][Full Text] [Related]
13. Brain magnetic resonance-imaging findings of anti-N-methyl-D-aspartate receptor encephalitis: a cohort follow-up study in Chinese patients.
Wang R; Lai XH; Liu X; Li YJ; Chen C; Li C; Chi XS; Zhou D; Hong Z
J Neurol; 2018 Feb; 265(2):362-369. PubMed ID: 29249055
[TBL] [Abstract][Full Text] [Related]
14. Frequent rhabdomyolysis in anti-NMDA receptor encephalitis.
Lim JA; Lee ST; Kim TJ; Moon J; Sunwoo JS; Byun JI; Jung KH; Jung KY; Chu K; Lee SK
J Neuroimmunol; 2016 Sep; 298():178-80. PubMed ID: 27609293
[TBL] [Abstract][Full Text] [Related]
15. Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour.
Wang BJ; Wang CJ; Zeng ZL; Yang Y; Guo SG
J Neurol Sci; 2017 Jun; 377():127-132. PubMed ID: 28477682
[TBL] [Abstract][Full Text] [Related]
16. Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review.
McKeon GL; Robinson GA; Ryan AE; Blum S; Gillis D; Finke C; Scott JG
J Clin Exp Neuropsychol; 2018 Apr; 40(3):234-252. PubMed ID: 28585453
[TBL] [Abstract][Full Text] [Related]
17. The Psychiatric Phenotype of Anti-NMDA Receptor Encephalitis.
Gibson LL; Pollak TA; Blackman G; Thornton M; Moran N; David AS
J Neuropsychiatry Clin Neurosci; 2019; 31(1):70-79. PubMed ID: 30376787
[TBL] [Abstract][Full Text] [Related]
18. Anti-N-methyl-D-aspartate receptor encephalitis: a prospective study focused on cerebrospinal fluid and clinical symptoms.
Wu S; Li H; Lian Y; Chen Y; Zheng Y; Wang C; Zhang Q; Huang Z; Mao Z; Pang K
Neurol Sci; 2020 Nov; 41(11):3255-3263. PubMed ID: 32399951
[TBL] [Abstract][Full Text] [Related]
19. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China.
Zhang Y; Liu G; Jiang MD; Li LP; Su YY
Clin Neurophysiol; 2017 Jul; 128(7):1227-1233. PubMed ID: 28527387
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent characteristics and prognostic factors of pediatric anti-N-methyl-d-aspartate receptor encephalitis in a Chinese single-center study.
Zhang W; Ren C; Wang X; Li J; Ding C; Han T; Lv J; Chen C; Gong S; Xiuwei Z; Dai L; Feng W; Yang X; Zhang S; Zhou J; Ren H; Guan H; Ren X; Fang F
Eur J Paediatr Neurol; 2021 Sep; 34():67-73. PubMed ID: 34399369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
